Regencell Bioscience Holdings Limited
General ticker "RGC" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $4.6B (TTM average)
Regencell Bioscience Holdings Limited does not follow the US Stock Market performance with the rate: -0.7%.
Estimated limits based on current volatility of 17.8%: low 27.51$, high 39.44$
Factors to consider:
- Total employees count: 13 as of 2021
Short-term RGC quotes
Long-term RGC plot
Financial data
| YTD | 2023-06-30 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $6.27MM | $4.74MM | $3.77MM |
| Operating Income | $-6.27MM | $-4.74MM | $-3.77MM |
| Non-Operating Income | $0.21MM | $0.37MM | $0.19MM |
| R&D Expense | $1.58MM | $1.07MM | $0.95MM |
| Income(Loss) | $-6.06MM | $-4.36MM | $-3.58MM |
| Profit(Loss)* | $-5.87MM | $-4.30MM | $-3.58MM |
| Stockholders Equity | $12.03MM | $8.22MM | $4.86MM |
| Inventory | $0.06MM | $0.00MM | $0.00MM |
| Assets | $12.62MM | $8.44MM | $5.76MM |
| Operating Cash Flow | $-4.96MM | $-4.00MM | $-3.11MM |
| Capital expenditure | $0.03MM | $0.01MM | $0.15MM |
| Investing Cash Flow | $0.06MM | $5.24MM | $2.69MM |
| Financing Cash Flow | $0.13MM | $0.10MM | $0.00MM |
| Earnings Per Share** | $-0.01 | $-0.01 | $-0.01 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.